tiprankstipranks
Trending News
More News >
Genmab A/S (DE:GE9)
XETRA:GE9

Compare Genmab A/S (GE9) vs. Competitors

Compare
14 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Genmab A/S
€290.70
kr18.55B
13.57
46.67%
4 Buy
2 Hold
0 Sell
Moderate Buy
Genmab A/S
kr2216.17
kr138.63B
13.85
47.57%
4 Buy
2 Hold
0 Sell
Moderate Buy
GlaxoSmithKline
1848.00p
£75.86B
13.90
39.21%
3 Buy
8 Hold
4 Sell
Hold
AstraZeneca
14026.00p
£222.43B
30.89
31.72%
12 Buy
2 Hold
1 Sell
Moderate Buy
Hikma Pharmaceuticals
1567.00p
£3.45B
12.09
-22.98%
5 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:GE9
Genmab A/S
290.70
86.00
42.01%
GB:0MGB
Genmab A/S
2,213.70
695.06
45.77%
GB:GSK
GlaxoSmithKline
1,848.00
556.32
43.07%
GB:AZN
AstraZeneca
14,026.00
3,411.82
32.14%
GB:HIK
Hikma Pharmaceuticals
1,562.00
-443.30
-22.11%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts